OSMOLEX ER is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Adamas Pharma, Llc. The primary component is Amantadine Hydrochloride.
| Product ID | 70482-075_8321bb20-293e-4848-b1be-3116bf9ca476 |
| NDC | 70482-075 |
| Product Type | Human Prescription Drug |
| Proprietary Name | OSMOLEX ER |
| Generic Name | Amantadine |
| Dosage Form | Tablet, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-06-01 |
| Marketing Category | NDA / |
| Application Number | NDA209410 |
| Labeler Name | Adamas Pharma, LLC |
| Substance Name | AMANTADINE HYDROCHLORIDE |
| Active Ingredient Strength | 129 mg/1 |
| Pharm Classes | Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2018-06-01 |
| NDC Exclude Flag | N |
| Sample Package? | Y |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 68025-021 | Osmolex ER | amantadine |
| 68025-074 | Osmolex ER | amantadine |
| 68025-075 | Osmolex ER | amantadine |
| 68025-076 | Osmolex ER | amantadine |
| 68025-077 | Osmolex ER | amantadine |
| 70482-075 | OSMOLEX ER | amantadine |
| 70482-076 | OSMOLEX ER | amantadine |
| 46708-246 | amantadine | amantadine |
| 46708-586 | Amantadine | Amantadine |
| 60687-422 | Amantadine | Amantadine |
| 62332-246 | amantadine | amantadine |
| 62332-586 | Amantadine | Amantadine |
| 70482-085 | GOCOVRI | AMANTADINE |
| 70482-170 | GOCOVRI | AMANTADINE |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() OSMOLEX ER 87639712 5770506 Live/Registered |
Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelôsségû Társaság 2017-10-10 |